• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同老年女性对人乳头瘤病毒检测与常规宫颈癌筛查的偏好

Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women.

作者信息

Huang Alison J, Pérez-Stable Eliseo J, Kim Sue E, Wong Sabrina T, Kaplan Celia P, Walsh Judith M E, Iwaoka-Scott A Yuri, Sawaya George F

机构信息

Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.

出版信息

J Gen Intern Med. 2008 Sep;23(9):1324-9. doi: 10.1007/s11606-008-0633-x. Epub 2008 May 28.

DOI:10.1007/s11606-008-0633-x
PMID:18506546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2518007/
Abstract

BACKGROUND

Human papillomavirus (HPV) testing is increasingly being used to determine the optimal cervical cancer screening interval in older women. Little is known about women's attitudes toward HPV testing or how these attitudes may influence medical discussions about cervical cancer screening.

METHODS

Preferences for HPV and concomitant Papanicolaou (Pap) testing were assessed through in-person interviews with diverse women aged 50 to 80 years recruited from community and university-based practices.

RESULTS

Eight hundred and sixty-five women (257 White, 87 African American, 149 Latina, and 372 Asian) were interviewed. Approximately 60% of participants wanted to be tested for HPV and another 15% would undergo testing if recommended by their physician. Among those wanting HPV testing, 94% would want more frequent than annual Pap tests if they had a positive HPV test and a normal Pap test. Two thirds of those under age 65 would be willing to switch to triennial Pap testing, and half of those aged 65 and older would be willing to discontinue Pap testing, if they had a negative HPV test and normal Pap test. Preferences for testing varied by ethnicity, age, place of birth, and cancer history.

CONCLUSIONS

The majority of older women were willing to use HPV testing to make decisions about frequency and duration of cervical cancer screening, but up to one third would want at least annual, ongoing screening regardless of HPV test results. Efforts should be made to ensure that HPV testing is used to reinforce appropriate utilization of screening tests.

摘要

背景

人乳头瘤病毒(HPV)检测越来越多地用于确定老年女性宫颈癌筛查的最佳间隔时间。对于女性对HPV检测的态度,以及这些态度如何影响关于宫颈癌筛查的医学讨论,我们知之甚少。

方法

通过对从社区和大学医疗机构招募的50至80岁不同女性进行面对面访谈,评估她们对HPV检测和同时进行巴氏(Pap)检测的偏好。

结果

共访谈了865名女性(257名白人、87名非裔美国人、149名拉丁裔和372名亚裔)。约60%的参与者希望进行HPV检测,另有15%的人表示如果医生建议就会接受检测。在希望进行HPV检测的人中,如果HPV检测呈阳性且巴氏检测正常,94%的人希望比每年进行一次巴氏检测的频率更高。如果HPV检测呈阴性且巴氏检测正常,65岁以下的人中三分之二愿意改为每三年进行一次巴氏检测,65岁及以上的人中一半愿意停止巴氏检测。检测偏好因种族、年龄、出生地和癌症病史而异。

结论

大多数老年女性愿意使用HPV检测来决定宫颈癌筛查的频率和持续时间,但高达三分之一的人无论HPV检测结果如何,都希望至少每年进行一次持续筛查。应努力确保HPV检测用于加强筛查检测的合理利用。

相似文献

1
Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women.不同老年女性对人乳头瘤病毒检测与常规宫颈癌筛查的偏好
J Gen Intern Med. 2008 Sep;23(9):1324-9. doi: 10.1007/s11606-008-0633-x. Epub 2008 May 28.
2
Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years.德国沃尔夫斯堡适应性风险 HPV 宫颈癌筛查项目——3 年多的经验。
J Clin Virol. 2009 Nov;46 Suppl 3:S5-10. doi: 10.1016/S1386-6532(09)70294-X.
3
Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.基线细胞学检查、人乳头瘤病毒检测与宫颈肿瘤发生风险:一项10年队列分析
J Natl Cancer Inst. 2003 Jan 1;95(1):46-52. doi: 10.1093/jnci/95.1.46.
4
Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.检测高危型(HR)人乳头瘤病毒(HPV)16、18 和 45 型在癌前宫颈病变中的诊断准确性的测定:初步数据。
J Clin Virol. 2009 Nov;46 Suppl 3:S11-5. doi: 10.1016/S1386-6532(09)70295-1.
5
Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.287 例宫颈鳞癌女性的癌症诊断相关筛查试验结果。
Arch Pathol Lab Med. 2012 Dec;136(12):1533-40. doi: 10.5858/arpa.2011-0609-OA. Epub 2012 Aug 20.
6
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.识别患有宫颈肿瘤的女性:对巴氏涂片结果不明确者使用人乳头瘤病毒DNA检测
JAMA. 1999 May 5;281(17):1605-10. doi: 10.1001/jama.281.17.1605.
7
Recent changes in cervical cancer screening guidelines: U.S. women's willingness for HPV testing instead of Pap testing.宫颈癌筛查指南的最新变化:美国女性对 HPV 检测而非 Pap 检测的意愿。
Prev Med. 2020 Jan;130:105928. doi: 10.1016/j.ypmed.2019.105928. Epub 2019 Nov 19.
8
The Acceptability and Preference of Vaginal Self-sampling for Human Papillomavirus (HPV) Testing among a Multi-ethnic Asian Female Population.多民族亚洲女性人群对人乳头瘤病毒(HPV)检测用阴道自我采样的可接受性和偏好。
Cancer Prev Res (Phila). 2021 Jan;14(1):105-112. doi: 10.1158/1940-6207.CAPR-20-0280. Epub 2020 Sep 11.
9
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.在常规临床实践中同时进行人乳头瘤病毒和宫颈细胞学检测的女性宫颈癌风险:一项基于人群的研究。
Lancet Oncol. 2011 Jul;12(7):663-72. doi: 10.1016/S1470-2045(11)70145-0. Epub 2011 Jun 16.
10
Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer.在宫颈癌高发国家寻找一种理想的宫颈癌筛查模型,以减少假阴性错误。
J Obstet Gynaecol. 2020 Feb;40(2):240-246. doi: 10.1080/01443615.2019.1621813. Epub 2019 Jul 25.

引用本文的文献

1
Short-term clinical and immunologic effects of poly-gamma-glutamic acid (γ-PGA) in women with cervical intraepithelial neoplasia 1 (CIN 1): A multicenter, randomized, double blind, phase II trial.多聚谷氨酸(γ-PGA)治疗宫颈上皮内瘤变 1 级(CIN1)的短期临床和免疫效果:一项多中心、随机、双盲、Ⅱ期临床试验。
PLoS One. 2019 Jun 20;14(6):e0217745. doi: 10.1371/journal.pone.0217745. eCollection 2019.
2
Acceptable and Preferred Cervical Cancer Screening Intervals Among U.S. Women.美国女性可接受的和首选的宫颈癌筛查间隔
Am J Prev Med. 2015 Dec;49(6):e99-107. doi: 10.1016/j.amepre.2015.04.025. Epub 2015 Jul 2.
3
Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening.患者对人乳头瘤病毒检测及常规宫颈癌筛查中5年间隔时间的担忧。
Obstet Gynecol. 2015 Feb;125(2):317-329. doi: 10.1097/AOG.0000000000000638.
4
Women's intentions to receive cervical cancer screening with primary human papillomavirus testing.女性接受人乳头瘤病毒检测进行宫颈癌筛查的意愿。
Int J Cancer. 2013 Dec 15;133(12):2934-43. doi: 10.1002/ijc.28324. Epub 2013 Jul 16.
5
Routine bimanual pelvic examinations: practices and beliefs of US obstetrician-gynecologists.美国妇产科医师常规双手骨盆检查:实践与信念。
Am J Obstet Gynecol. 2013 Feb;208(2):109.e1-7. doi: 10.1016/j.ajog.2012.11.015. Epub 2012 Nov 22.
6
Colorectal cancer screening: what do women from diverse ethnic groups want?结直肠癌筛查:不同族裔的女性有何需求?
J Gen Intern Med. 2013 Feb;28(2):239-46. doi: 10.1007/s11606-012-2210-6. Epub 2012 Sep 12.
7
Are women ready for the new cervical screening protocol in England? A systematic review and qualitative synthesis of views about human papillomavirus testing.英国新的宫颈癌筛查方案,女性准备好了吗?关于人乳头瘤病毒检测的系统评价和定性综合分析。
Br J Cancer. 2012 Jul 10;107(2):243-54. doi: 10.1038/bjc.2012.256. Epub 2012 Jun 14.
8
Using visual displays to communicate risk of cancer to women from diverse race/ethnic backgrounds.利用视觉呈现来向不同种族/族裔背景的女性传达癌症风险。
Patient Educ Couns. 2012 Jun;87(3):327-35. doi: 10.1016/j.pec.2011.11.014. Epub 2012 Jan 12.
9
Trends of human papillomavirus testing in cervical cancer screening at a large academic cytology laboratory.大型学术细胞学实验室宫颈癌筛查中人类乳头瘤病毒检测的趋势。
Obstet Gynecol. 2011 Aug;118(2 Pt 1):289-295. doi: 10.1097/AOG.0b013e3182253c33.
10
How does public policy impact cervical screening and vaccination strategies?公共政策如何影响宫颈癌筛查和疫苗接种策略?
Gynecol Oncol. 2010 Nov;119(2):175-80. doi: 10.1016/j.ygyno.2010.08.021.

本文引用的文献

1
Association between cancer risk perception and screening behavior among diverse women.不同女性群体中癌症风险认知与筛查行为之间的关联。
Arch Intern Med. 2008 Apr 14;168(7):728-34. doi: 10.1001/archinte.168.7.728.
2
Human papillomavirus and Papanicolaou tests to screen for cervical cancer.人乳头瘤病毒和巴氏涂片检查用于宫颈癌筛查。
N Engl J Med. 2007 Oct 18;357(16):1589-97. doi: 10.1056/NEJMoa073204.
3
Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.人乳头瘤病毒DNA检测与巴氏涂片检查用于宫颈癌筛查的比较
N Engl J Med. 2007 Oct 18;357(16):1579-88. doi: 10.1056/NEJMoa071430.
4
2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests.2006年宫颈癌筛查异常女性管理共识指南
Am J Obstet Gynecol. 2007 Oct;197(4):346-55. doi: 10.1016/j.ajog.2007.07.047.
5
Prevalence of HPV infection among females in the United States.美国女性人乳头瘤病毒(HPV)感染率
JAMA. 2007 Feb 28;297(8):813-9. doi: 10.1001/jama.297.8.813.
6
Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: projections from the National Health Interview Survey (NHIS).人乳头瘤病毒(HPV)检测、HPV疫苗研发以及筛查频率变化对全国巴氏试验量的影响:来自国家健康访谈调查(NHIS)的预测
Cancer. 2007 Feb 25;111(1):34-40. doi: 10.1002/cncr.22487.
7
Knowledge about cervical cancer risk factors, traditional health beliefs, and Pap testing among Vietnamese American women.美籍越南女性对宫颈癌风险因素、传统健康观念及巴氏试验的认知。
J Immigr Minor Health. 2007 Apr;9(2):109-14. doi: 10.1007/s10903-006-9025-7.
8
Breast and cervical cancer screening for Puerto Ricans, African Americans, and non-Hispanic whites attending inner-city family practice centers.针对在市中心家庭医疗中心就诊的波多黎各人、非裔美国人及非西班牙裔白人的乳腺癌和宫颈癌筛查。
Ethn Dis. 2006 Autumn;16(4):994-1000.
9
A content analysis of news coverage of the HPV vaccine by U.S. newspapers, January 2002-June 2005.对2002年1月至2005年6月美国报纸关于人乳头瘤病毒(HPV)疫苗新闻报道的内容分析。
J Womens Health (Larchmt). 2006 Sep;15(7):803-9. doi: 10.1089/jwh.2006.15.803.
10
Patients' anxiety and expectations: how they influence family physicians' decisions to order cancer screening tests.患者的焦虑与期望:它们如何影响家庭医生开具癌症筛查检查的决定。
Can Fam Physician. 2005 Dec;51(12):1658-9.